
Read More
Biopharmaceutical Company-Zydus launches biosimilar Aflibercept 2 mg ANYRA ...
The introduction of Anyra™ addresses a pressing healthcare challenge in India, where over 100 millio...

The introduction of Anyra™ addresses a pressing healthcare challenge in India, where over 100 millio...

The shares of the company have a PE of 120x with just 40 per cent returns in just 2 years....

This marks a historic milestone as the first and only treatment approved in the United States for Me...